BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 32204380)

  • 1. The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases.
    Rozpędek-Kamińska W; Siwecka N; Wawrzynkiewicz A; Wojtczak R; Pytel D; Diehl JA; Majsterek I
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32204380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Basis of Human Diseases and Targeted Therapy Based on Small-Molecule Inhibitors of ER Stress-Induced Signaling Pathways.
    Rozpedek W; Nowak A; Pytel D; Diehl JA; Majsterek I
    Curr Mol Med; 2017; 17(2):118-132. PubMed ID: 28266275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of disordered neurodegenerative function: concepts and facts about the different roles of the protein kinase RNA-like endoplasmic reticulum kinase (PERK).
    Taalab YM; Ibrahim N; Maher A; Hassan M; Mohamed W; Moustafa AA; Salama M; Johar D; Bernstein L
    Rev Neurosci; 2018 Jun; 29(4):387-415. PubMed ID: 29303785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Small molecule inhibitors of PERK-dependent signaling pathway as a novel, therapeutic molecular strategy in Alzheimer's disease treatment].
    Rozpędek W; Pytel D; Diehl JA; Majsterek I
    Pol Merkur Lekarski; 2016 Jul; 41(241):5-10. PubMed ID: 27734813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unfolded Protein Response and PERK Kinase as a New Therapeutic Target in the Pathogenesis of Alzheimer's Disease.
    Rozpedek W; Markiewicz L; Diehl JA; Pytel D; Majsterek I
    Curr Med Chem; 2015; 22(27):3169-84. PubMed ID: 26282939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Potential therapeutic application of PERK inhibitors].
    Basak J; Rozpędek W; Pytel D; Majsterek I
    Postepy Biochem; 2019 Jun; 65(2):118-127. PubMed ID: 31642650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-rich foods, sea foods, and gut microbiota amplify immune responses in chronic diseases and cancers - Targeting PERK as a novel therapeutic strategy for chronic inflammatory diseases, neurodegenerative disorders, and cancer.
    Saaoud F; Lu Y; Xu K; Shao Y; Praticò D; Vazquez-Padron RI; Wang H; Yang X
    Pharmacol Ther; 2024 Mar; 255():108604. PubMed ID: 38360205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the PERK-Dependent Unfolded Protein Response Signaling Pathway Involved in the Pathogenesis of Alzheimer's Disease.
    Rozpędek W; Pytel D; Popławski T; Walczak A; Gradzik K; Wawrzynkiewicz A; Wojtczak R; Mucha B; Diehl JA; Majsterek I
    Curr Alzheimer Res; 2019; 16(3):209-218. PubMed ID: 30819079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase R(PKR)-like endoplasmic reticulum kinase (PERK) inhibitors: a patent review (2010-2015).
    Axten JM
    Expert Opin Ther Pat; 2017 Jan; 27(1):37-48. PubMed ID: 27646439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The unfolded protein response in neurodegenerative disorders - therapeutic modulation of the PERK pathway.
    Hughes D; Mallucci GR
    FEBS J; 2019 Jan; 286(2):342-355. PubMed ID: 29476642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoplasmic Reticulum Stress and Unfolded Protein Response in Neurodegenerative Diseases.
    Ghemrawi R; Khair M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the unfolded protein response in neurodegeneration: A new approach to therapy.
    Halliday M; Mallucci GR
    Neuropharmacology; 2014 Jan; 76 Pt A():169-74. PubMed ID: 24035917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of PERK in Understanding Development of Neurodegenerative Diseases.
    Smedley GD; Walker KE; Yuan SH
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of ER stress and apoptosis by hydrogen peroxide in HeLa cells: protective role of mild heat preconditioning at 40°C.
    Pallepati P; Averill-Bates DA
    Biochim Biophys Acta; 2011 Dec; 1813(12):1987-99. PubMed ID: 21875624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderate endoplasmic reticulum stress activates a PERK and p38-dependent apoptosis.
    Lumley EC; Osborn AR; Scott JE; Scholl AG; Mercado V; McMahan YT; Coffman ZG; Brewster JL
    Cell Stress Chaperones; 2017 Jan; 22(1):43-54. PubMed ID: 27761878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Common Cellular Events in the Neurodegenerative Diseases and the Associated Role of Endoplasmic Reticulum Stress.
    Kim S; Kim DK; Jeong S; Lee J
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Niskocząsteczkowe inhibitory szlaku adaptacyjnej odpowiedzi na stres zależnego od kinazy PERK jako nowatorska strategia terapeutyczna w leczeniu choroby Alzheimera].
    Rozpędek W; Pytel D; Diehl JA; Majsterek I
    Pol Merkur Lekarski; 2019 Jan; 46(271):9-15. PubMed ID: 30810108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PERK-opathies: An Endoplasmic Reticulum Stress Mechanism Underlying Neurodegeneration.
    Bell MC; Meier SE; Ingram AL; Abisambra JF
    Curr Alzheimer Res; 2016; 13(2):150-63. PubMed ID: 26679859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule strategies to harness the unfolded protein response: where do we go from here?
    Grandjean JMD; Wiseman RL
    J Biol Chem; 2020 Nov; 295(46):15692-15711. PubMed ID: 32887796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PERK Pathway and Neurodegenerative Disease: To Inhibit or to Activate?
    Shacham T; Patel C; Lederkremer GZ
    Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33652720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.